Still over 440 000 people die from malaria every year, most of them in sub-Saharan Africa.
The updated global research agenda for malaria eradication, 'malERA Refresh,' calls for new medicines and tools as well as integrated approaches to address current challenges and ultimately eradicate malaria. MalERA Refresh is the result of a consultative process with over 180 international experts led by renowned malaria scientists including former Swiss TPH Director Marcel Tanner. To accelerate the fight against malaria and address current challenges, the new global research agenda for malaria - malERA Refresh - calls for innovation and integrated approaches in science and Research&Development (R&D), namely: Iterative innovation (e.g. new medicines and tools for vector control) Transformative innovation such as new tools and strategies to reduce or halt parasite transmission (e.g. gene drive technologies) Integrated approaches tailored to local health systems and local variations in disease transmission dynamics "MalERA Refresh will give new momentum to science and R&D in the public and private sectors to make elimination of malaria possible," said Marcel Tanner, former director of the Swiss Tropical and Public Health Institute (Swiss TPH) and chair of the WHO Scientific Advisory Group on Malaria Eradication. "More than ever, we need coordinated action by all stakeholders." The recommendations of malERA Refresh were published today in a series of seven papers as a special collection in PLOS Medicine. Driving Research in Malaria MalERA Refresh, which updates the first Malaria Eradication Research Agenda (malERA) of 2011, is the result of a two-year consultative process involving more than 180 scientists, malaria programme leaders and policy makers from around the world, including Don de Savigny and Fabrizio Tediosi from Swiss TPH.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
